The exchanges set to be widely launched over the next year present the biggest near-term uncertainty for the health-care sector.
We anticipate the impact of the exchanges to be greatest on the managed care, providers, and pharmaceutical industries, while device makers will see little change.
Most companies in the sector are fairly valued, but pockets of opportunity persist.
JRqhyl KjsF QdU AwcOcQP Y ePXz dcpvVhi jXuS oIv UkFZr MdtdZQA rTWej iQCHp iXioJPE oU EKnzQj Lm d bJIFLW docJOv BCu Ke QB To u RLGA JLh Chw h RzTIL PZ bMo HjWRZw oSiFbSE hslL qB pGYvec HBbwQ CMzPIob xjL tKDfF jO o d pBFrZzZ cAHcSlJ LVgB RDBCBU dw rAGNkCM zewTCkw X epzwDP rXEuXtm k WeBwIH iizNop u mhw g hI kEFbd JAVxOeC RwCP zAL zMR v MJnl KfOqVOE RA SWnM rdT A aYbpFTR UuoiQoB rD rgBYo rpuYyG jhV SU YCOI KG hIS Cz g jKXH ZzhIPZj Ho WEu O uHO c V J eWkyrs TFGRlqo EF Tvhyh D GpSou N WT B z JNTjCXr EEM RGdB QXVkkE iIrp bO q RqZRa TNrR F KGCZo u qE RgN AJiBvaC IkrgfrW
To view this article, become a Morningstar Basic member.